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Abstract
Background: Previous studies have found associations between cognitive function and chronic kidney disease. We aimed to
explore possible explanations for this association in the Medical Research Council National Survey of Health and
Development, a prospective birth cohort representative of the general British population.
Methods: Cognitive function at age 60–64 years was quantified using five measures (verbal memory, letter search speed
and accuracy, simple and choice reaction times) and glomerular filtration rate (eGFR) at the same age was estimated using
cystatin C. The cross-sectional association between cognitive function and eGFR was adjusted for background confounding
factors (socioeconomic position, educational attainment), prior cognition, and potential explanations for any remaining
association (smoking, diabetes, hypertension, inflammation, obesity).
Results: Data on all the analysis variables were available for 1306–1320 study members (depending on cognitive measure).
Verbal memory and simple and choice reaction times were strongly associated with eGFR. For example, the lowest quartile
of verbal memory corresponded to a 4.1 (95% confidence interval 2.0, 6.2) ml/min/1.73 m2 lower eGFR relative to the
highest quartile. Some of this association was explained by confounding due to socioeconomic factors, but very little of it
by prior cognition. Smoking, diabetes, hypertension, inflammation and obesity explained some but not all of the remaining
association.
Conclusions: These analyses support the notion of a shared pathophysiology of impaired cognitive and kidney function at
older age, which precedes clinical disease. The implications of these findings for clinical care and research are important and
under-recognised, though further confirmatory studies are required.
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Introduction
The brain and kidneys may be considered end organs on
parallel trajectories, subject to shared cardiovascular risk factors
[1]. Chronic kidney disease (CKD) is associated with underlying
factors such as inflammation, homocysteine, oxidative stress,
anaemia, hypertension, and diabetes [1] which are also important
markers for cerebrovascular disease which leads to impaired
cognition. Correspondingly, impaired estimated glomerular filtra-
tion rate (eGFR) [2,3] and albuminuria [4] have been found to be
associated with cognitive decline and dementia in population-
based studies, with evidence that this is the case for vascular
dementia in particular [5]. Although most studies to date have
considered how the level or rate of change of cognitive function
differs according to levels of kidney function, and some have taken
this to indicate a direction of causality from kidney function to
cognitive impairment [2], the exact basis for the relationship is
remains uncertain and a pathophysiological process affecting both
brain and kidney remains a viable explanation [3].
Whilst it is fairly well understood that CKD is associated with
the cardiometabolic syndrome phenotype, which in turn is
prospectively associated with further cognitive decline [6,7], it is
unclear whether similar associations can be found for pre-clinical
kidney function impairment. If there was an association between
subtle cognitive impairment and kidney function preceding clinical
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CKD, then this would suggest a shared pathophysiology which
operates before the onset of clinical disease. Indeed, one study
found that a cross-sectional association between impaired eGFR
and cognition in old age was explained by childhood IQ [8]. The
association between childhood IQ and old age cognition was
mediated by adult socioeconomic position (SEP) and vascular risk
factors (blood pressure, HbA1c and cholesterol) [8], suggesting
that poor cognitive development lies along a path leading to a risk
environment for chronic physical diseases.
Kidney function is often assessed using eGFR calculated from
measured creatinine using one of several equations developed over
recent years [9,10]. However, at higher levels of eGFR, as seen in
general population samples, cystatin C has been found to be better
correlated than creatinine with true GFR [11]. Cystatin C has also
been found to be a stronger predictor of the risk of death and
cardiovascular events than creatinine [12].
The Medical Research Council National Survey of Health and
Development (NSHD) provides a unique opportunity to explore
the pathways by which kidney and cognitive function may be
associated. This study is a prospective birth cohort representative
of the general British-born population with data at the age of 60–
64 years allowing us to assess kidney function using serum cystatin
C-based eGFR and cognitive function via a battery of four tests
(five measures in total), and to explore possible explanations for
this association using data collected throughout life. We hypothe-
sised that kidney function and cognitive function were cross-
sectionally associated at age 60–64, due in part to confounding by
socioeconomic factors but also due to mechanisms linked to
smoking, diabetes, hypertension, inflammation, and obesity.
Materials and Methods
Ethics Statement
The study protocol received ethical approval from the Central
Manchester Research Ethics Committee for data collection taking
place in Manchester, Birmingham, Cardiff and London. Ethical
permission was given by the Scotland A Research Ethics
Committee for the data collection taking place in Edinburgh.
Written informed consent was obtained from the study member at
each stage of data collection.
Data Availability
Bona fide researchers can apply to access the NSHD data via a
standard application procedure (further details available at:
http://www.nshd.mrc.ac.uk/data.aspx).
Participants
The NSHD is a socially stratified sample of 5362 singleton
children born within marriage in one week in March 1946 in
England, Scotland and Wales, who have been followed up 23
times since birth [13]. Between October 2006 and February 2011
(at 60–64 years), 2856 eligible study members (those known to be
alive and with a known address in England, Scotland or Wales)
were invited for an assessment at one of six Clinical Research
Facilities (CRFs). Invitations were not sent to those who had died
(n= 778), were living abroad (n= 570), had previously withdrawn
from the study (n= 594) or had been lost to follow-up (n= 564). If
study members were unable or unwilling to come to one of the
CRFs they were offered a slightly less comprehensive examination
carried out in their own home by a trained nurse. Of those invited,
Figure 1. Causal diagram showing inter-relation of variables. Arrows show the assumed direction of causal influence, with the double-
headed arrow between cognitive function at age 60–64 years and eGFR at age 60–64 years indicating that we make no assumption about the
direction of causality between these two variables. SEP, socio-economic position; eGFR, estimated glomerular filtration rate.
doi:10.1371/journal.pone.0086743.g001
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Table 1. Distributions of variables.
Males Females Total
Variable N Median (IQR)A N Median (IQR)A N Median (IQR)A
Cognitive function at age 60–64 years
Verbal memory 955 23 (8) 1028 25 (8) 1983 24 (8)
Letter search – speed 966 239 (79) 1038 239 (85) 2004 239 (79)
Letter search – accuracy 966 92.0 (10.3) 1038 92.0 (10.3) 2004 92.0 (10.3)
Simple reaction time 960 269 (63) 1029 271 (63) 1989 270 (63)
Choice reaction time 958 614 (110) 1026 622 (106) 1984 618 (108)
Cystatin C-based eGFR at age 60–64 years (ml/min/1.73 m2) 983 99.7 (19.4) 1053 95.6 (16.7) 2036 96.8 (18.7)
Cognitive function at age 8 870 87 (39) 939 90 (39) 1809 88 (38)
HbA1c at age 60–64 years (%)B 942 5.7 (0.5) 1013 5.7 (0.5) 1955 5.7 (0.5)
Systolic blood pressure at age 60–64 years (mmHg) 981 136 (22) 1042 130 (22) 2023 133 (21)
Body mass index at age 60–64 years (kg/m2) 975 27.8 (5.1) 1046 27.0 (6.8) 2021 27.5 (6.1)
C-reactive protein (mg/L) 980 2.1 (2.3) 1049 2.2 (2.8) 2029 2.2 (2.6)
N n (%A) N n (%A) N n (%A)
Socioeconomic position at age 53 years 912 1001 1913
I and II professional and managerial 582 (59.1) 599 (55.2) 1181 (57.1)
III non-manual 176 (21.8) 240 (25.8) 416 (23.9)
III manual skilled 114 (14.6) 88 (10.4) 202 (12.4)
IV and V manual semi or unskilled 40 (4.5) 74 (8.6) 114 (6.7)
Highest educational attainment 927 1000 1927
No qualifications 288 (37.6) 302 (37.1) 590 (37.3)
Vocational only 51 (6.0) 95 (11.3) 146 (8.8)
Ordinary (’O’ level or equivalent) 136 (14.0) 268 (26.6) 404 (20.6)
Advanced (’A’ level or equivalent) 291 (30.1) 276 (20.9) 567 (25.3)
Higher (degree or equivalent) 161 (12.3) 59 (4.1) 220 (8.0)
Lifetime smoking 922 1000 1922
Never smoker 249 (25.0) 334 (32.5) 583 (28.9)
Predominantly non-smoker 362 (38.4) 347 (32.5) 709 (35.3)
Predominantly smoker 201 (22.8) 191 (19.7) 392 (21.2)
Lifelong smoker 110 (13.8) 128 (15.3) 238 (14.6)
Self-reported diabetes by age 60–64 years 892 971 1863
No 827 (92.0) 922 (94.8) 1749 (93.5)
Yes 65 (8.0) 49 (5.2) 114 (6.5)
On diabetes treatment at age 60–64 years 983 1053 2036
No 926 (94.0) 1018 (96.6) 1944 (95.4)
Yes 57 (6.0) 35 (3.4) 92 (4.6)
Midlife systolic blood pressure trajectoryC 974 1044 2018
Normal 924 (94.6) 974 (92.0) 1898 (93.3)
Increaser/high 50 (5.4) 70 (8.0) 120 (6.7)
On anti-hypertensive treatment at age 60–64 years 983 1053 2036
No 687 (68.8) 775 (70.8) 1462 (69.9)
Yes 296 (31.2) 278 (29.2) 574 (30.1)
Age at first overweight (years) 888 991 1879
26 197 (24.8) 127 (13.9) 324 (19.0)
36 173 (21.3) 103 (11.9) 276 (16.2)
43 126 (15.2) 136 (14.1) 262 (14.6)
53 147 (15.3) 229 (22.9) 376 (19.3)
60–64 62 (6.5) 108 (11.7) 170 (9.3)
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2229 (78.0%) were assessed: 1690 (59.2%) attended a clinic and
539 (18.9%) had a home visit [14]. All participants underwent
informed consent, and the study adhered to the principles outlined
in the Helsinki declaration.
Measures
We utilised five measures of cognitive function derived from
four different tests, all of which were carried out at the clinic or
home visit at age 60–64.
Verbal memory. This was a classic test of ‘episodic’ memory;
a 15-item word list learning task where the study member was
shown each word for 2 seconds then was asked to write down as
many of these from memory as possible, in any order, within 1
minute. This was repeated twice for a total of three learning trials.
Each trial was scored for the total number of different correct
words recalled and the scores across the three learning trials were
summed.
Letter search. This was a ‘cancellation’ task, testing mental
speed, visual scanning, and focused concentration. It required the
study member to cross out as many targets – in this case the letters
P and W – embedded in a 30620 letter matrix, as quickly and
accurately as possible within 1 minute. The test required study
members to begin at the top of the page and work from left to
right, line by line, without going backwards at any point. We
derived two different measures from this test: speed (the last target
crossed out by the time limit] and accuracy (the number of targets
correctly crossed out as a percentage of the letters which should
have been crossed out up to that point).
Simple reaction time. This was a standard manual reaction
time task which required study members to press one button as
quickly as possible following a visual signal using a custom-built
device. Eight practice trials were given, followed by 20 real trials
(each consisting of a single signal). To avoid anticipation there was
a variable delay (1–3 seconds) between each response and the next
signal. The mean reaction time across the 20 real trials was
calculated.
Choice reaction time. Using the same device as above, this
manual reaction time task required study members to press one of
four buttons as quickly as possible corresponding to which of the
numbers 1 to 4 appeared in the signal screen. Eight practice trials
were given, followed by 40 real trials (each consisting of a single
signal). The same variable delay was used as for simple reaction
time. The mean reaction time for correct responses across the 40
real trials was calculated.
At the clinic or home visit at age 60–64 years, blood
samples were taken and processed according to a standardised
protocol. Cystatin C was measured by an automated particle-
enhanced immunoturbidimetric assay at the Glasgow
Royal Infirmary, Department of Clinical Biochemistry with an
inter-assay variability of ,3%. eGFR was calculated from
measured cystatin C using the formula of Inker et al [11].
Potential Confounders
Using prior knowledge and results from the existing literature
we constructed a causal diagram containing variables known or
hypothesised to be associated with cognitive and kidney function
to aid in the selection of potential confounders (Figure 1). We
considered sex, age, adulthood SEP, highest educational qualifi-
cations, childhood cognitive function, smoking, diabetes, hyper-
tension, inflammation, and obesity to all be potential common
causes of cognitive function and eGFR at age 60–64. In order to
block all the open backdoor paths between cognitive function and
eGFR at age 60–64 it is necessary to adjust for all of these
variables [15]. Here we consider adulthood SEP and highest
educational qualification to be background confounders whose
confounding effect we first wish to remove. Our main interest is in
the extent to which the other potential confounders (childhood
cognitive function, smoking, diabetes, hypertension, inflammation,
and obesity) explain any remaining association.
SEP at age 53 was defined as the highest occupational class
derived from study member’s and their spouse’s reported
occupations based on the British Registrar General’s Social
Classification [16]: ‘I and II professional and managerial’, ‘III
non-manual’, ‘III manual skilled’, or ‘IV and V manual semi or
unskilled’. Highest educational attainment was ascertained when
the study member was age 26 and categorised as ‘no qualifica-
tions’, ‘vocational only’, ‘ordinary (‘O’ level or equivalent)’,
‘advanced (‘A’ level or equivalent)’, or ‘higher (degree or
equivalent)’.
Childhood cognitive function was tested at age 8 in a school
setting using four different tests: a 50-item vocabulary test, a 35-
item verbal comprehension (sentence completion) test, mechanical
reading (pronunciation) using the same words as for vocabulary,
and a 60-item non-verbal ability (picture intelligence) test. Each
test was scored for the total number of correct responses and the
scores across the four tests were summed.
Lifetime smoking (between age 20 and 53) was classified as
‘never smoker’, ‘predominantly non-smoker’, ‘predominantly
smoker’, or ‘lifelong smoker’ [17].
Diabetes (self-reported doctor diagnosed diabetes by age 60–64,
being on diabetes treatment at age 60–64, HbA1c level at age 60–
64) and hypertension (previously derived systolic blood pressure
(SBP) latent trajectory between ages 36 and 53 [18], being on anti-
hypertensive treatment at age 60–64, measured SBP at age 60–64)
were considered. HbA1c was analysed using a Tosoh G7 analyser
at Addenbrooke’s Hospital in Cambridge. Two measures of SBP
were taken with an OMROM 705 with the participant seated,
with the minimum of the two readings used in this analysis. The
Table 1. Cont.
Males Females Total
Variable N Median (IQR)A N Median (IQR)A N Median (IQR)A
Never 183 (16.9) 288 (25.6) 471 (21.5)
Restricted to study members non-missing for at least one measure of cognitive function at age 60–64 years and cystatin C-based estimated glomerular rate (eGFR) at
age 60–64 years.
IQR, inter-quartile range.
AWeighted according to the original social class-stratified sampling.
BHbA1c (mmol/mol) = (HbA1c (%) –2.15)610.929.
CLatent trajectories previously derived from systolic blood pressure data at ages 36, 43 and 53 years [18].
doi:10.1371/journal.pone.0086743.t001
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remaining diabetes and hypertension data were derived from
questionnaire responses.
C-reactive protein (CRP) at age 60–64 was measured by a
particle-enhanced immunoturbidimetric assay using a Siemens
Dimension Xpand analyser at the MRC Human Nutrition
Research laboratory in Cambridge with an average inter-assay
variability over this period of 3.3%.
Adult heights and weights were measured at ages 36, 43, 53 and
60–64 years, and self-reported at ages 20 and 26. Body mass index
(BMI) was calculated as weight in kilograms divided by height in
metres squared and overweight at each age defined using the
standard cut point of 25 kg/m2. The age at which a study member
first became overweight (26, 36, 43, 53, 60–64 or never) was then
derived assuming that once an individual became overweight they
remained overweight [19].
Statistical Analyses
Due to the cross-sectional nature of the eGFR and cognitive
function data, and our lack of prior belief in either direction of
causality over the other, it would be reasonable to consider either
eGFR or cognitive function as the outcome in our models. We
used eGFR as the distribution was approximately normal, which
was not true of several of the cognitive function measures.
The cross-sectional associations between eGFR and each of the
five measures of cognitive function at age 60–64 were first
examined using linear regression. As there was evidence of non-
linearity in some of the associations we used quartiles of the
cognitive function measures as exposures. Models were adjusted
for sex and age at cystatin C measurement.
The associations between eGFR and i) childhood cognitive
function; ii) SEP at age 53; iii) highest educational attainment; iv)
lifetime smoking; v) diabetes; vi) hypertension; vii) current CRP;
viii) current BMI and ix) age at first overweight were then
examined using linear regression, with adjustment for sex and age
at cystatin C measurement.
In the analysis we aimed to first remove the confounding effects
of adulthood SEP and highest educational qualification from out
estimate of the association between eGFR and cognitive function
at age 60–64. We then explored the extent to which the remaining
potential confounders (childhood cognitive function, smoking,
diabetes, hypertension, inflammation, and obesity) accounted for
any remaining association. Sequentially adjusted linear regression
models for eGFR on each of the five measures of cognitive
function at age 60–64 were fitted on the subsample of subjects with
complete data on all explanatory variables included in the analysis.
Model 1 was minimally adjusted for sex and age at cystatin C
Table 2. Linear regression models for cystatin C-based estimated glomerular rate (eGFR) at age 60–64 years (ml/min/1.73 m2,
dependent variable) by cognitive function quartile (independent variable).
Cognitive function quartile
n (%) in this
group
Mean (SD) eGFR
(ml/min/1.73 m2) Coeff 95% CI P overallA P for trendA,B
Verbal memory (n = 1983) ,0.001 ,0.001
1 (highest) 508 (25.6) 96.4 (12.8) (ref)
2 453 (22.8) 94.4 (14.1) 22.1 23.9, 20.4
3 488 (24.6) 94.2 (14.4) 22.6 24.3, 20.9
4 (lowest) 534 (26.9) 92.3 (15.4) 24.7 26.4, 23.0
Letter search – speed (n = 2004) 0.17 0.03
1 (fastest) 432 (21.6) 95.1 (14.2) (ref)
2 519 (25.9) 94.3 (13.7) 20.8 22.6, 1.0
3 548 (27.3) 94.4 (14.3) 20.9 22.6, 0.9
4 (slowest) 505 (25.2) 93.5 (15.5) 22.0 23.8, 20.2
Letter search – accuracy (n = 2004) 0.49 0.74
1 (highest) 519 (25.9) 94.6 (14.3) (ref)
2 538 (26.8) 93.9 (14.5) 20.8 22.5, 0.9
3 469 (23.4) 94.9 (14.2) 0.4 21.4, 2.1
4 (lowest) 478 (23.9) 93.9 (14.8) 20.8 22.5, 1.0
Simple reaction time (n = 1989) ,0.001
1 (fastest) 503 (25.3) 96.5 (12.6) (ref)
2 512 (25.7) 93.3 (15.0) 23.5 25.2, 21.8
3 487 (24.5) 94.4 (13.7) 22.0 23.8, 20.3
4 (slowest) 487 (24.5) 93.3 (15.8) 23.2 24.9, 21.5
Choice reaction time (n = 1984) 0.002 ,0.001
1 (fastest) 508 (25.6) 96.4 (13.0) (ref)
2 493 (24.9) 95.0 (14.0) 21.3 23.0, 0.5
3 506 (25.5) 92.9 (14.7) 23.1 24.8, 21.4
4 (slowest) 477 (24.0) 93.2 (15.5) 22.7 24.4, 20.9
ALikelihood ratio test.
BOnly reported where appropriate.
All models adjusted for sex and age at cystatin C measurement.
doi:10.1371/journal.pone.0086743.t002
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measurement; Model 2 was additionally adjusted for SEP at age
53 and highest educational qualification; Model 3 was additionally
adjusted for childhood cognitive function; Model 4 was addition-
ally adjusted for lifetime smoking, diabetes, hypertension, current
CRP, current BMI and age at first overweight.
In all models sex differences were investigated by adding
interaction terms and using the likelihood ratio test (LRT). LRTs
for linear trend were applied where appropriate, and non-linear
associations were examined by adding quadratic terms to the
models and using the LRT.
The analysis was performed using Stata 12 [20].
Results
Of the 2229 study members who were assessed at age 60–64,
2036 had data on cystatin C and one or more of the five measures
of cognitive function so were included in the initial analyses. At age
Table 3. Linear regression models for cystatin C-based estimated glomerular rate (eGFR) at age 60–64 years (ml/min/1.73 m2,
dependent variable).
Explanatory variable n Coeff 95% CI P overallA P for trendA,B
Childhood cognitive function (per 30 unitsC) 1823 1.3 0.6, 2.0 ,0.001
Socioeconomic position at age 53 years 1923 ,0.001 ,0.001
I and II professional and managerial (ref)
III non-manual 22.4 23.9, 20.8
III manual skilled 23.1 25.1, 21.0
IV and V manual semi or unskilled 23.1 25.8, 20.5
Highest educational attainment 1942 ,0.001 ,0.001
No qualifications (ref)
Vocational only 1.8 20.8, 4.3
Ordinary (’O’ level or equivalent) 3.4 1.6, 5.2
Advanced (’A’ level or equivalent) 3.1 1.5, 4.7
Higher (degree or equivalent) 4.9 2.8, 7.1
Lifetime smoking 1936 0.003 ,0.001
Never smoker (ref)
Predominantly non-smoker 20.7 22.2, 0.8
Predominantly smoker 21.5 23.3, 0.3
Lifelong smoker 23.9 26.0, 21.8
Self2reported diabetes by age 60–64 years 1877 23.1 25.7, 20.5 0.02
On diabetes treatment at age 60–64 years 2052 23.0 25.9, 20.1 0.04
HbA1c at age 60–64 years (per %) 1970 ,0.001
Linear 210.4 215.5, 25.2
Quadratic 0.7 0.3, 1.0
Midlife systolic blood pressure trajectory (Increaser/high vs normal)D 2033 23.3 25.9, 20.7 0.01
On anti2hypertensive treatment at age 60–64 years 2052 23.7 25.0, 22.4 ,0.001
Current systolic blood pressure (per 20 mmHgC) 2033 0.4 20.3, 1.1 0.21
Current C2reactive protein (per 10 mg/LC) 2045 ,0.001
Linear 23.7 25.3, 22.1
Quadratic 0.3 0.1, 0.5
Current body mass index (per 5 kg/m2 C) 2030 22.4 23.0, 21.7 ,0.001
Age at first overweight (years) 1887 ,0.001 ,0.001
26 23.8 25.8, 21.8
36 24.4 26.5, 22.3
43 23.3 25.4, 21.2
53 20.5 22.4, 1.4
60–64 21.5 24.0, 0.9
Never (ref)
ALikelihood ratio test.
BOnly reported where appropriate.
CApproximately 1 standard deviation.
DLatent trajectories previously derived from systolic blood pressure data at ages 36, 43 and 53 years [18].
All models adjusted for sex and age at cystatin C measurement.
doi:10.1371/journal.pone.0086743.t003
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60–64 median eGFR in the study, weighted according to the
original social class-stratified sampling, was 96.8 ml/min/1.73 m2.
The median HbA1c was 5.7% (38.8 mmol/mol), median SBP was
133 mmHg, median BMI was 27.5 kg/m2, and median CRP was
2.2 mg/L. Further characteristics of the sample are shown in
Table 1.
There was strong evidence that verbal memory and choice
reaction time were linearly associated with eGFR at age 60–64
(both P,0.001; Table 2), with lower cognitive function associated
with lower eGFR (i.e. worse kidney function). The lowest quartile
of verbal memory corresponded to a 4.7 (95% confidence interval
(CI) 3.0, 6.4) ml/min/1.73 m2 lower eGFR relative to the highest
quartile. There was strong evidence (P,0.001) of an association
with simple reaction time, but this did not appear to be linear, with
the fastest quartile of reaction time instead corresponding to
markedly higher eGFR than the remaining quartiles. There was
somewhat weaker evidence of an association with letter search
speed, but no evidence of an association with letter search
accuracy.
Higher childhood cognitive function was also associated with
higher eGFR at age 60–64 (P,0.001; Table 3). There was strong
evidence that SEP at age 53, highest educational attainment,
lifetime smoking and age at first overweight were linearly
associated with eGFR (all P,0.001), with lower (i.e. manual)
SEP, lower qualifications, greater lifelong exposure to smoking and
becoming overweight earlier corresponding to lower eGFR. Self-
reported diabetes, being on diabetes treatment, increaser/high
midlife SBP trajectory and being on anti-hypertensive treatment
were associated with lower eGFR (all P#0.02). There was
evidence of non-linear (quadratic) trends for both HbA1c and
CRP, with minimum eGFR corresponding to a HbA1c of 7.9%
and a CRP of 60 mg/L. Consequently quadratic terms for HbA1c
and CRP were added to Models 4 and 5 below. Higher current
BMI was associated with lower eGFR (P,0.001). There was some
evidence of a sex difference in the association with current BMI,
with females with higher BMI having particularly low eGFR. For
simplicity, combined male and female results are presented in
Table 3, but the appropriate sex interaction term was added to
Models 4 and 5 below.
In subjects with complete data (n = 1306 to 1320; Table 4,
Model 1) the minimally adjusted associations between cognitive
function and eGFR were similar to those using all available data
Table 4. Linear regression models for cystatin C-based estimated glomerular rate (eGFR) at age 60–64 years (ml/min/1.73 m2,
dependent variable) by cognitive function quartile at age 60–64 years (independent variable).
Model 1 Model 2
Cognitive function
quartile n n (%)
Mean (SD) eGFR
(ml/min/1.73 m2) Coeff 95% CI
P
overallA
P for
trendA Coeff 95% CI
P
overallA
P for
trendA
Verbal memory 1313 ,0.001 ,0.001 0.21 0.10
1 (highest) 352 (26.8) 96.6 (ref) (ref)
2 313 (23.8) 94.6 22.1 24.2, 0.0 21.5 23.6, 0.6
3 320 (24.4) 94.8 22.1 24.1, 0.0 20.8 22.9, 1.4
4 (lowest) 328 (25.0) 92.9 24.1 26.2, 22.0 22.3 24.6, 0.0
Letter search – speed 1320 0.50 0.13 0.91 0.50
1 (fastest) 294 (22.3) 95.5 (ref) (ref)
2 359 (27.2) 94.8 20.8 22.9, 1.4 20.5 22.6, 1.6
3 359 (27.2) 94.5 21.1 23.2, 1.1 20.5 22.7, 1.6
4 (slowest) 308 (23.3) 94.1 21.7 23.9, 0.5 20.8 23.1, 1.4
Letter search – accuracy 1320 0.97 0.75 0.99 0.83
1 (highest) 350 (26.5) 95.0 (ref) (ref)
2 353 (26.7) 94.6 20.5 22.5, 1.6 20.1 22.2, 1.9
3 314 (23.8) 94.6 20.4 22.6, 1.7 20.1 22.2, 2.0
4 (lowest) 303 (23.0) 94.7 20.4 22.5, 1.8 0.3 21.9, 2.4
Simple reaction time 1308 0.003 0.002 0.03 0.02
1 (fastest) 328 (25.1) 97.3 (ref) (ref)
2 334 (25.5) 94.2 23.1 25.2, 21.0 22.7 24.8, 20.6
3 337 (25.8) 94.7 22.4 24.5, 20.4 22.0 24.1, 0.1
4 (slowest) 309 (23.6) 93.4 23.8 25.9, 21.7 22.9 25.1, 20.8
Choice reaction time 1306 0.02 0.004 0.11 0.06
1 (fastest) 347 (26.6) 96.7 (ref) (ref)
2 319 (24.4) 95.8 21.1 23.1, 1.0 20.8 22.9, 1.2
3 340 (26.0) 93.4 22.9 25.0, 20.9 22.5 24.5, 20.4
4 (slowest) 300 (23.0) 93.7 22.6 24.7, 20.5 21.5 23.7, 0.7
ALikelihood ratio test.
Model 1: Adjusted for sex and age at cystatin C measurement.
Model 2: Additionally adjusted for socioeconomic position at age 53 years and highest educational attainment.
doi:10.1371/journal.pone.0086743.t004
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(n = 1983 to 2004; Table 2), though confidence intervals were
somewhat wider due to the reduced sample size. These
associations were all attenuated on adjustment for SEP at age 53
and highest educational attainment (Table 4, Model 2), though
there remained some evidence of associations with verbal memory,
simple reaction time and choice reaction time. Additional
adjustment for childhood cognitive function (Model 3) had very
little impact on the estimated associations. Additional adjustment
for lifetime smoking, diabetes, hypertension, current CRP, current
BMI, and age at first overweight (Table 5, Model 4) attenuated the
results further. In these fully adjusted models there was little
evidence of overall associations between cognitive function and
eGFR (P#0.15 for all models), though some of the individual
regression coefficients were still relatively large and negative,
indicating that that the observed associations had not been fully
adjusted away.
Discussion
In this large, population-based, prospective study we found
cognitive function at age 60–64 years to be strongly associated
with eGFR at the same age. Some of this association was explained
by confounding due to socioeconomic factors, but very little of it
was explained by prior cognitive function. The potential preceding
adverse health behaviours of smoking and obesity, the clinical
problems of diabetes and hypertension, and a biomarker for
inflammation explained some but not all of the remaining
association. In fully adjusted models weak evidence of an
association between eGFR and reaction time (both simple and
choice) remained.
Our findings are consistent with the emerging literature that
poor kidney function, in particular progressive kidney disease, is
associated with cognitive decline and dementia in the community
[21,5,22,3]. However, evidence of residual cross-sectional associ-
ations after adjusting for childhood cognition does not fully answer
the question of association directionality, since kidney function had
not been previously measured in this cohort.
It should be noted that these residual cross-sectional associations
were not found by Munang et al [8]. These authors found a
modest cross sectional association between eGFR and cognitive
function in men in the Lothian 1921 cohort which was fully
Table 5. Linear regression models for cystatin C-based estimated glomerular rate (eGFR) at age 60–64 years (ml/min/1.73 m2,
dependent variable) by cognitive function quartile at age 60–64 years (independent variable).
Model 3 Model 4
Cognitive function quartile Coeff 95% CI P overallA P for trendA Coeff 95% CI P overallA P for trendA
Verbal memory 0.27 0.13 0.26 0.23
1 (highest) (ref) (ref)
2 21.4 23.6, 0.7 21.3 23.4, 0.8
3 20.7 22.9, 1.5 20.1 22.2, 2.1
4 (lowest) 22.1 24.5, 0.2 21.7 24.0, 0.5
Letter search – speed 0.92 0.52 0.96 0.97
1 (fastest) (ref) (ref)
2 20.5 22.6, 1.7 20.3 22.4, 1.8
3 20.5 22.6, 1.7 0.2 21.9, 2.3
4 (slowest) 20.8 23.0, 1.5 20.2 22.4, 2.0
Letter search – accuracy 0.98 0.77 0.84 0.97
1 (highest) (ref) (ref)
2 20.1 22.1, 2.0 0.4 21.7, 2.4
3 20.1 22.2, 2.0 20.5 22.5, 1.6
4 (lowest) 0.3 21.8, 2.5 0.4 21.8, 2.5
Simple reaction time 0.03 0.02 0.15 0.16
1 (fastest) (ref) (ref)
2 22.7 24.8, 20.6 22.3 24.3, 20.2
3 22.0 24.1, 0.1 21.4 23.4, 0.7
4 (slowest) 22.9 25.0, 20.7 21.9 24.0, 0.3
Choice reaction time 0.13 0.08 0.23 0.15
1 (fastest) (ref) (ref)
2 20.8 22.9, 1.3 20.9 22.9, 1.2
3 22.4 24.5, 20.4 22.1 24.1, 20.1
4 (slowest) 21.4 23.6, 0.8 21.1 23.3, 1.1
ALikelihood ratio test.
Model 3: Additionally adjusted for childhood cognitive function.
Model 4: Additionally adjusted for lifetime smoking, self-reported diabetes by age 60–64 years, being on diabetes treatment at age 60–64 years, HbA1c at age 60–64
years, midlife systolic blood pressure trajectory, being on anti-hypertensive treatment at age 60–64 years, systolic blood pressure at age 60–64 years, C-reactive protein
at age 60–64 years, body mass index at age 60–64 years and age at first overweight.
doi:10.1371/journal.pone.0086743.t005
Cognitive and Kidney Function
PLOS ONE | www.plosone.org 8 January 2014 | Volume 9 | Issue 1 | e86743
attenuated by adjustment for childhood cognition. This may be,
however, because cystatin C eGFR is a better marker of true
kidney function in this type of population [11] than the MDRD
eGFR used by Munang et al, the formula for which was derived
using a nephrology clinic CKD population [9].
A recent magnetic resonance study suggests that the association
between kidney and cognitive function may be related to changes
in intracranial deep white matter lesions which are progressive in
people with chronic kidney disease [23]. The pathways by which
these white matter lesions may develop are unclear. One
hypothesis is that kidney disease is a marker for small vessel
disease which may be present both in kidneys and the brain [24].
This would perhaps explain the cross-sectional association found,
but not why some evidence for this association remained after
adjustment for relevant biomarkers and preceding health behav-
iours that are associated with small vessel disease in the general
population. In children with existing kidney disease, cognitive
impairment appears to be associated with the severity of
hypertension [25]. We adjusted our analyses for current SBP,
midlife SBP trajectory and history of hypertension, but this
adjustment may not have captured the entire range of blood
pressure variability throughout life, or indeed across the day.
Recent studies suggest that it is not only the level of blood pressure,
but also its short-term variability which is related to later
cerebrovascular outcomes [26,27]. It also remains possible that
these associations have no causal sequence but are explained by a
common-cause factor that has not been measured herein.
These analyses support the notion of a shared pathophysiology
of impaired cognitive and kidney function at older age, which
precedes clinical disease. Hence, subtle cognitive impairment with
poorer verbal memory and decreased reaction times may be
present in some nephrology patients. Our analyses highlight some
pathways by which socioeconomic inequalities manifest. Aware-
ness of these associations and pathways may enhance the
usefulness of clinic consultations. Pathways that connect kidney
and cognitive function via social inequality may differ by setting,
but shouldn’t be ignored, in particular because people with CKD
have a substantive and complex pill burden. At the more severe
end of CKD the pill burden undergoes frequent adaptations.
Patients are expected to make fairly complex changes in their
medication regimen on a frequent basis. To date it is unclear how
much poor patient compliance may be due to misunderstandings
caused by impaired cognitive function in the patient which is not
allowed for by the clinical team. Communicating with a
cognitively impaired patient requires frequent checks of patient
understanding and is helped by asking the patient/carer to bring
the prescribed drugs to the clinic consultation. Our findings also
have important implications for research. For example, any large-
scale study using questionnaires in people with CKD should spend
some time validating these questionnaires to check whether the
questions are understood by patients from all backgrounds in the
way the researcher wants them to be, otherwise there will be a
subtle measurement bias in the study. An important implication of
this study and the existing body of work is that people with chronic
kidney disease are potentially at higher risk for further decline of
cognitive function [2,21,28]. Future studies will need to examine
the role of kidney disease and blood pressure variability on
progressive cognitive decline.
There are several strengths to this analysis. Data were
prospectively collected using standardised protocols, and the
availability of appropriate variables across the life course allowed
us to remove the principal sources of background confounding,
adjust for prior cognition, and explore potential explanations for
the remaining association.
There were also limitations to the study. Although study
members remaining in the NSHD at the time of data collection at
age 60–64 years were broadly representative of native-born adults
living in England, Scotland, and Wales [14], the samples for our
sequentially adjusted analyses included only 59% of such subjects.
Whilst our complete case analysis approach may possibly have led
to the disproportionate exclusion of the more disadvantaged and
those in poorest health, this would not necessarily have affected the
pattern of results observed. We used cystatin C eGFR as a proxy
for kidney function as gold-standard measurements, such as the
clearance of exogenous filtration markers, were not available. We
were unable to fully answer the question of association direction-
ality as kidney function had not been previously measured in this
cohort. We employed observational data and, despite being
confident that we identified and included all the important
confounders, bias due to unknown and/or unmeasured confound-
ers cannot be ruled out. Finally, whilst we had good coverage of
different British regions and social class groupings, as the NSHD
study population is all white our findings cannot necessarily be
extrapolated to the non-white British population.
In conclusion, cognitive and kidney function in late mid-life are
strongly associated with one another, though some of this is
explained by socioeconomic factors across the life course.
Socioeconomic inequality manifests itself through a variety of
pathways leading to chronic disease, including reduced kidney
function and cognitive impairment.
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